Navigation Links
BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
Date:9/22/2009

NOVATO, Calif., Sept. 22 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). Initial top-line results are expected in mid-2010.

"We remain optimistic on this program and believe that, if approved, PEG-PAL may offer a significant benefit for many PKU patients, especially those who do not respond adequately to Kuvan," said Hank Fuchs, M.D., Chief Medical Officer of BioMarin. "In our view, the flexible design of the Phase 2 protocol provides multiple opportunities to arrive at an optimal dose and dosing frequency that is tolerable in at least in a sub-segment of the PKU population. We are encouraged by the results of the Phase 1 study, which showed a substantial blood Phe level reduction across all patients in the fifth cohort at a dose of 0.1mg/kg, no serious adverse events, and reactions as expected with a protein of this nature.

The Phase 2 clinical trial is an open-label, multi-center study to be conducted in up to 35 patients in a series of dose-escalating cohorts from 0.001 mg/kg. The primary treatment period of eight once weekly injections at a fixed dose will be followed by eight weeks of dose and frequency optimization and an extension period where doses can be increased up to 2.0 mg/kg/week.

The primary objective is to evaluate the effect of PEG-PAL on blood Phe concentrations in subjects with PKU. The secondary objectives are to evaluate the safety and tolerability, immune response and steady state pharmacokinetics of subcutaneous injections of multiple dose levels of PEG-PAL.

Abou
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces FDA Approval for Kuvan
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
7. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
8. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
9. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
10. Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
11. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... MADISON HEIGHTS, Mich. , April 21, 2015 /PRNewswire/ ... national provider of infusion pumps and related services for ... and Canada , announces ... subsidiary of substantially all of the assets of Ciscura ... Alpharetta, GA , was a privately-held ...
(Date:4/21/2015)... 2015 Gary A. Puckrein , PhD, ... Forum (NMQF), today will present an award to ... Research and Manufacturers of America (PhRMA), for his ... behalf of PhRMA, and in conjunction with NMQF, Castellani ... awareness, start conversations, and increase diversity in clinical trials, ...
(Date:4/21/2015)... , April 21, 2015  A new, cutting edge ... Coast that promises to revolutionize the way prostate cancer ... the world-renowned Montsouris Institute in Paris, France ... biopsy in the North Florida / ... technology in prostate cancer diagnosis and management to ...
Breaking Medicine Technology:InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 3InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 4National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 2Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 3
(Date:4/21/2015)... (PRWEB) April 21, 2015 Among parents ... their child’s dental health as fair or poor, according ... is not surprising, as a visit to the dentist ... The sensory overload from the strange smells, loud noises, ... looming; and the unpredictability of the whole process—not knowing ...
(Date:4/21/2015)... 21, 2015 The California Healthcare ... leading life sciences organizations, released the following statement ... California State Assembly Bill (AB) 463: , “As ... the development of treatments and cures for patients ... concerns regarding AB 463, the so-called Pharmaceutical Cost ...
(Date:4/21/2015)... April 21, 2015 AvePoint, ... and devices, today announced a new enhancement to ... new Microsoft Office 365 Management Activity API. This integration ... fully audit and take action on all events that ... new Office 365 Management Activity API provides customers with ...
(Date:4/21/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining ... SUVs. , SUVs are large vehicles that fare well ... and a smaller regular car shows that passengers from the ... SUV safer in crashes, but these large vehicles may be ... , It is now possible to find low cost car ...
(Date:4/21/2015)... April 21, 2015 Carinsurancehints.com has released ... and explaining their impact on auto insurance prices ... increase auto insurance prices. Clients should review their insurance ... can be bought under several forms. Some of the ... , rivers can compare online rates and find the ...
Breaking Medicine News(10 mins):Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2
... 3 Hong Ray Enterprises of,Shijiazhuang, China, the world,s ... of nitrile gloves, has notified Medline,Industries, Inc., and other ... that they will be unable to meet their normal,agreements ... supplier., "This disruption to supply will have a ...
... SCHAUMBURG, Ill., July 3 From Midwest floods, to,wildfires ... and have cost dearly in life and livelihood. Many ... up in shelters, waiting for,their owners to claim them., ... also created a,deluge of painful lessons in disaster preparedness ...
... in Spanish . , ,Scientists of the University ... confirmed that stem cells from human umbilical cord blood can ... such as hepatitis, and therefore mean an effective alternative to ... shortly published in the renowned journal Cell Transplantation, ...
... 3 Senetek PLC (OTC,Bulletin Board: SNKTY), ... development,of technologies that target the science of ... License Agreement with Ardana Bioscience,Limited ("Ardana"). The ... and distribute Invicorp(R) in Europe and was ...
... CHICAGO, July 3 Rising Medical Solutions, Inc.,(Rising), ... has extended its offerings in California to include,Utilization ... Bill Review and,Medical Provider Network (MPN) services in ... a corporate wide effort to provide a full-service,managed ...
... for young athletes, , , THURSDAY, July 3 (HealthDay ... "Knocking the cobwebs loose." , Shop-worn sports cliches ... But new research suggests that high school football ... a concussion and managing the problem, although there,s ...
Cached Medicine News:Health News:Medline Receives Force Majeure Notice From Hong Ray Enterprises 2Health News:AVMA Collections Highlights Disaster Preparedness 2Health News:Stem cells from umbilical cord used in the treatment of hepatic diseases 2Health News:Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited 2Health News:Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program 2Health News:Playing It Safe With High School Sports 2Health News:Playing It Safe With High School Sports 3Health News:Playing It Safe With High School Sports 4
... VP1500 Digital Documentation System brings intra-operative image ... of convenience. This system combines cutting edge ... provide you with the best possible outcome. ... digital stills or moving video clips: CD ...
Linvatecs single CCD camera heads offer high resolution with the convenience of programmable buttons for sterile field control of the printer and VCR. Available in "V and "C mount in NTSC and PAL....
... Stryker's leadership in minimally invasive surgery ... Stryker offers a full line of 3-Chip ... other video accessories to meet your demanding ... have long been hallmarks of our 3-Chip ...
... The high-resolution 1-Chip Camera System provides ... gain, and small scope. The camera head ... design., ,VCM 12, Complete 1-Chip Camera ... Camera Control Unit (CCU) with power cord ...
Medicine Products: